key: cord-0752263-p7t33t3d
authors: Ealey, Kafi N.; Phillips, Joy; Sung, Hoon-Ki
title: COVID-19 and obesity: Fighting two pandemics with intermittent fasting
date: 2021-06-25
journal: Trends Endocrinol Metab
DOI: 10.1016/j.tem.2021.06.004
sha: 15c5ec28858cc549366a0ce1cc875ac600bcd63b
doc_id: 752263
cord_uid: p7t33t3d

Obesity is strongly and independently associated with an increased risk of severe illness and death from coronavirus disease (COVID-19). The pathophysiological changes that result from elevated body weight lead to metabolic dysfunction, chronic inflammation, impaired immunological responses and multi-system disorders which increase vulnerability to severe illness from COVID-19. While vaccination strategies are underway across the world, the second and third waves of the pandemic, along with the emergence of novel SARS-CoV-2 strains, continue to threaten the stability of medical systems worldwide. Furthermore, evidence from previous pandemics suggests that vaccines are less effective in obese individuals than in their healthy-weight counterparts over the long-term. Therefore, a consideration of lifestyle changes that can boost metabolic health and immunity is critical to reduce the risk of complications and severe illness from viral infection. In this review we discuss the potential mechanisms linking excess body weight with COVID-19 morbidity. We also present evidence that intermittent fasting, a dietary program that has gained popularity in recent years, may be an effective strategy to improve metabolic health and immunity and thus reduce the impact of obesity on COVID-19 morbidity and mortality.

Diabetes, a common comorbidity of COVID-19, is associated with a higher risk of excessive uncontrolled inflammatory responses, higher computerized tomography (CT) imaging scores indicating SARS-CoV-2 pneumonia, an increased likelihood of mechanical ventilation and a shorter duration of survival, even after adjusting for other co-morbidities (e.g., age, sex, hypertension and cardiovascular disease) [14] [15] [16] . Studies point to hyperglycemia, resulting from poor glycemic control, as a driver of COVID-19 progression and poor prognosis [17] [18] [19] . In one large retrospective, multicenter study of over 7,000 patients with COVID-19 in Wuhan, China, among a cohort with COVID-19 and type 2 diabetes mellitus (T2DM), individuals with wellcontrolled blood glucose exhibited significant reductions in adverse outcomes, major organ injuries, all-cause mortality, and overall comorbidities compared to those with poor glycemic control [18] . In other studies, elevated fasting blood glucose at the time of admission was associated with longer hospitalization, higher levels of in-hospital complications and mortality [20] [21] [22] . Thus, fasting blood glucose at the time of admission was reported to be the best predictor of radiographic imaging of SARS-CoV-2 [21] and was an independent predictor of mortality, regardless of past medical history of diabetes [20] [21] [22] .

interfering with glucose metabolism and/or glucose utilization pathways may prevent deadly cytokine storms. The expression of IRF5 and its related pro-inflammatory cytokines was associated with the severity and prognosis of community-acquired pneumonia influenza virus infection [24] . Furthermore, IRF5, a marker of metabolic inflammation, has also been reported to be significantly elevated in the subcutaneous adipose tissues of diabetic obese patients compared to diabetic lean/overweight individuals [25] and is implicated in macrophage polarization toward a pro-inflammatory M1 phenotype [25, 26] (Figure 1 ). Inhibition of IRF-5 signaling pathways has been proposed as a potential therapy for severe COVID-19 [27] .

Increased glycolysis exacerbated by elevated glucose levels was shown to promote SARS-CoV-2 replication and pro-inflammatory cytokine secretion in monocytes [8] . Accordingly, monocytes isolated from obese diabetic patients that were infected with SARS-CoV-2 exhibited increased viral load compared to monocytes from healthy controls, providing further evidence that hyperglycemic individuals may be more susceptible to severe COVID-19 [8] . Furthermore, mitochondrial reactive oxygen species production, induced by SARS-CoV-2 infection, led to the stabilization of hypoxia-inducible factor-1 (HIF-1which upregulates glycolytic genes. Thus, uncontrolled hyperglycemia may create a permissive environment for SARS-CoV-2 by increasing glycolytic flux [8] .

The relationship between expression of ACE2, the SARS-CoV-2 receptor and COVID-19 pathogenesis is unclear (see Box 3), however hyperglycemia could lead to increased glycosylation of ACE2, which is thought to be important for its function and may facilitate viral J o u r n a l P r e -p r o o f Journal Pre-proof entry [28, 29] . Expression of glycosylated ACE2 rather than total ACE2 is associated with viral binding and fusion in the lung [30] .

The accumulation of excess adipose tissue leads to a state of chronic inflammation characterized by a phenotypic shift from an anti-inflammatory to a pro-inflammatory metabolic milieu with increased secretion of pro-inflammatory cytokines and dysfunctional immune responses that could play a major role in predisposing individuals to severe COVID-19 [7, 31] (Figure 3 ). At least one-third of circulating IL-6, a central driver of inflammation and a strong clinical predictor of disease severity and mortality resulting from COVID-19 infection, is estimated to come from adipose tissue [32, 33] . Compared to patients with non-severe COVID-19, patients with severe COVID-19 had significantly higher baseline circulating IL-6 levels upon admission, which increased over the course of the disease, suggesting that baseline circulating IL-6 may be a prognostic marker of COVID-19 [13] . Similarly, high serum IL-6, IL-8, and TNF- at baseline (i.e., at the time of hospitalization) are strong and independent predictors of patient survival [12] .

Circulating leptin is well known to be elevated in obese individuals [7, 31] . High levels of circulating leptin and selective leptin resistance have been implicated in impaired immune response to viral infection, diminished vaccine response, and chronic low-grade inflammation [34] . Leptin could be a key contributor to acute respiratory distress syndrome (ARDS) and cytokine storms during the advanced stages of COVID-19. Obese mice challenged with H1N1 J o u r n a l P r e -p r o o f Journal Pre-proof infection developed more extensive lung inflammation and damage as well as enhanced proinflammatory cytokine expression compared to lean mice [35] . Importantly, leptin inhibition with an anti-leptin antibody improved the cytokine profiles and survival rates of these obese mice [35] . In one cross-sectional study of ICU patients in the Netherlands, patients with COVID-19 had significantly higher serum leptin levels compared to their BMI-matched controls (who did not have COVID-19) [36] . Circulating leptin, together with IL-6, CXCL-10 and TNF-⍺, has been reported to be significantly associated with severe COVID-19 illness and inflammatory monocyte activation [37] .

In a recent study, obese mice inoculated with a human influenza virus had increased disease severity and viral spread [38] . Moreover, viruses from obese hosts had increased replicative ability, genetic diversity, and virulence [38] . Memory T cell responses, which are critical for conferring immunological memory and serve as major components of vaccination strategies, are impaired in obese individuals [39, 40] . Among adults who received influenza vaccines, those who were obese, were twice as likely to develop influenza or influenza-like disease compared to healthy weight counterparts, despite having similar antibody titers one month after influenza vaccination [10] . In addition, CD4+ and CD8+ T cell activation and cytotoxicity, which correlate with disease protection, were defective in cells taken from obese individuals compared to those taken from healthy individuals [10, 11] . Obesity was also associated with attenuated influenza vaccine responses, reduced circulating switched memory B cells, and increased proinflammatory late/exhausted dysfunctional B cells [41] . Leptin resistance may be implicated in these responses. The downregulation of leptin receptor (LEPR) and the upregulation of J o u r n a l P r e -p r o o f Journal Pre-proof suppressors of cytokine signaling (e.g., SOCS1 and SOCS3), which contribute to leptin resistance, led to decreased maintenance of influenza-specific CD8+ effector memory T-cells in the lungs of a diet induced obese mouse model 84 days post-influenza infection [39] .

As COVID-19 vaccines continue to gain widespread regulatory approval globally, these data are critically relevant to the overall long-term success of COVID-19 vaccine strategies. According to published clinical trial results, Pfizer-BioNTech's COVID-19 vaccine was 95% effective in preventing COVID-19 disease, including in people with obesity (BMI 30), who comprised onethird of participants in the clinical trial [42] . Similarly, in the Moderna vaccine trial, vaccine efficacy in participants with severe obesity (BMI 40) was comparable (>90%) to other participants at low-risk [43] . Thus, the evidence suggests that this higher risk group responds extremely well to the vaccine in the short-term. However, it remains unclear how well obese individuals maintain long-term SARS-CoV-2 vaccine-induced immunity ( Figure 3 ). One recent study, published as a pre-print, reported that the Pfizer vaccine was less effective in people with obesity as healthcare workers with obesity produced significantly less antibodies in response to vaccination compared to those classified as normal-weight [44] . Further, compared to lean COVID-19 patients, obese patients were reported to have significantly lower serum levels of SARS-CoV-2-specific IgG antibodies which negatively correlated with BMI and serum-levels of pro-inflammatory markers [45] . These data, while preliminary, indicate that the dysfunctional immune responses in obesity may extend to COVID-19.

J o u r n a l P r e -p r o o f Journal Pre-proof Aside from the lungs, the gastrointestinal (GI) system is likely another target of SARS-CoV-2, as clinical presentations of GI symptoms in COVID-19 patients have been well documented [46] , and viral fecal RNA is known to be present in a significant proportion of COVID-19 patients [47] . Relative to other human tissues, ACE2 is highly expressed in small intestinal enterocytes [48] . In addition to the potential role of the gut as a direct entry point for SARS-CoV-2, poor gut health could have important implications for the severity and outcomes of COVID-19. Gut barrier dysfunction and an altered gut microbiome are hallmark changes associated with obesity [49] . Changes in the composition of the gut microbiome have been postulated to play a role in abnormal immune responses and the severity of COVID-19 [50, 51] , although substantial evidence for this is forthcoming. Constant interactions between the mammalian host and its commensal gut microbes are crucial for proper immune system development, maintenance, and function [52] . While gut dysbiosis has been widely observed in a number of chronic inflammatory conditions, including obesity, dramatic dysbiosis has also been observed in critically ill patients and is hypothesized to be involved in the pathogenesis of ARDS and sepsis [53] . Accordingly, patients positive for COVID-19 exhibited significant gut dysbiosis, with decreased microbiota diversity and increased opportunistic pathogens that persisted even after clearance of the virus [50, 54] . Another study found that COVID-19 patients had significantly altered microbiome compared to non-COVID-19 controls and that microbiota composition was associated with disease severity [51] . Given that persistent dysbiosis is frequently observed in COVID-19 patients, improving the parameters of the gut microbiome could ameliorate long-term complications and accelerate recovery from COVID-19 [51] .

Increased gut barrier permeability in individuals with obesity and T2DM is associated with leakage of bacteria and bacterial products into the circulation which leads to metabolic J o u r n a l P r e -p r o o f endotoxemia, a major contributor to inflammation [49, 55] . It is postulated that enhanced synergistic interactions of bacterial and viral pathogens, can potentiate lung injury suggesting a mechanism by which gut barrier dysfunction in obesity and T2DM may worsen severity of COVID-19 [49] .

Compelling evidence from human and animal studies indicates that IF regimens (Box 2) promote numerous metabolic benefits, including weight loss, reduced adiposity and improved glucose homeostasis ( Figure 2 ) [56] . One group used a mobile application to track the eating patterns of healthy adults and found that over half of the individuals exhibited erratic eating patterns, consuming food for an average of 15 hours/day [57] . Shifting overweight individuals to a TRF regimen in which they consumed food within a daily 10-11hr window resulted in body weight reductions [57] . Furthermore, restricting daily food intake to an 8-10 hr duration resulted in significant reductions in body weight and adiposity and improved glucose tolerance in overweight/obese adults [58, 59] ; this intervention also reduced abdominal adiposity in individuals who exhibited one or more components of the metabolic syndrome [60] . Similarly, 4hr and 6hr TRF regimens were found to correspond to reductions in body weight, fat mass, markers of oxidative stress, and fasting insulin as well as improved insulin sensitivity in a group of obese individuals [61] . A short-four day 6hr early TRF regimen decreased mean 24-hr glucose levels in overweight adults [62] . One study reported positive metabolic effects of IF that were independent of weight reduction. In men at risk for T2DM, 5 weeks of 6-hr early TRF (in which all calories are consumed early in the day) resulted in improvements in insulin sensitivity, reduced markers of oxidative stress and reduced blood pressure even in the absence of weight J o u r n a l P r e -p r o o f reduction and without change in overall energy expenditure compared to individuals who consumed calories over a 12-hr period [63] . Similarly, isocaloric IF improved glucose tolerance in genetically obese mice in the absence of weight or fat mass reduction [64] .

Mice consuming an isocaloric 2:1 IF diet (two days feeding, one day fasting) for 16 weeks were protected from diet-induced obesity and exhibited improved glucose homeostasis and increased insulin sensitivity compared to ad libitum (AL)-fed mice [65] . In mice consuming various obesogenic diets, limiting food access to 8-9h during the active phase prevented body weight gain and fat accumulation, reversed pre-existing obesity and glucose intolerance, and reduced markers of adipose tissue inflammation in obese mice, regardless of diet and caloric intake [66] .

Glucose-lowering dipeptidyl-peptidase-4 (DPP4) inhibitors, which are widely used in treatment of T2DM, have been proposed as a strategy to offset the severity of COVID-19 infection [67, 68] .

However, evidence for this application is scant and more studies on this intervention are needed.

Notably, DPP4 plays a role in glucose and insulin metabolism and is positively correlated with adipocyte inflammation and insulin resistance [69] . DPP4 inhibitors act as agonists of the gut hormone glucagon-like peptide 1 (GLP-1) receptor, leading to increased circulating GLP-1 levels, improved pancreatic islet responses, and enhanced glucose homeostasis [69] (Figure 1 ). In obese mice, IF increased the secretion of GLP-1 [64] , which could improve insulin sensitivity by essentially mimicking the function of DPP4 inhibitors. Taken together, these findings suggest that through improvements in glucose homeostasis and adiposity, IF and TRF diet regimens could lower the risk of severe COVID-19 complications.

J o u r n a l P r e -p r o o f

Evidence for the prognostic role of inflammatory factors and defective immune cells in weakened responses to SARS-CoV-2 infection raises the possibility that strategies to modulate these circulating factors or boost memory T cells could potentially improve the immune response to COVID-19. Concomitant with improvements in glucose homeostasis, some studies have also reported reductions in inflammatory cytokines with IF [70, 71] , although others report no change in these markers despite other metabolic improvements [58, 61, 63] . Ramadan fasting, observed by millions of Muslims globally, involves daily diurnal IF for a period of 12-19 hours. Both during and outside the month of Ramadan, IF has been shown to decrease circulating TNF-⍺, IL-1ß, and IL-6 levels compared to non-fasting baseline levels, accompanied by significant weight loss and improved glucose metabolism [71, 72] . Similarly, intermittent caloric restriction in rodents significantly reduced circulating and adipose tissue levels of IL-6, TNF-⍺, IGF-1 and leptin compared to AL-fed mice [70] . Fasting and IF strategies have been shown to lower leptin levels [66, 70] and correct immune defects associated with ageing and other conditions characterized by dysregulated leptin signaling, including obesity, metabolic syndrome, and autoimmunity [65, 73, 74] . In a mouse model of a chronic inflammatory disease, a six-week alternate-day fasting (ADF) protocol prior to disease onset led to reduced pro-inflammatory monocyte numbers during disease development and downregulated expression of pro-inflammatory genes TNF-⍺, IL-1ß, CXCL2, and CXCL10 in monocytes compared to an AL feeding group [75] . In addition, shortterm fasting reduced monocyte numbers and the frequency of circulating and tissue-resident proinflammatory monocytes in humans and mice, respectively [75] .

A calorie-restricted (CR) diet in mice led to the homing of memory T cells to a bone marrow (BM) niche from which these cells were rapidly mobilized during secondary infection, providing enhanced protection against subsequent microbial challenge and prolonging host survival compared to AL-fed mice [76] . Given the similar responses of the CR and IF regimens, it is plausible that IF could also promote BM storage of memory T cells. Multiple cycles of a prolonged 48hr fast led to the renewal and regeneration of hematopoietic stem cells and reduced circulating IGF-1 levels, suggesting that cycles of fasting and refeeding can alter the frequency and composition of circulating immune cells infiltrating peripheral tissues and lead to a reset of the immune system [77] . These findings raise the possibility that IF could potentially reverse immune deficits in obese individuals, thus serving as a preventative, disease-mitigating approach to lower the risk of COVID-19 complications and potentially increase vaccine success (Figure 3 ).

As recently reviewed, IF may also boost the host immune system by activating pathways involved in autophagy [78] . While obesity, hypernutrition and associated lipotoxicity have been associated with attenuation of autophagic processes [79] , caloric restriction regimens enhance autophagy through AMP-activated protein kinase negative regulation of mammalian target of rapamycin (mTOR) [78] . Autophagy improves the body's ability to handle cellular stress and primes the host immune system by strengthening the survival and responses of T and B cells as well as antigen-presenting cells, which could prevent severe complications of SARS-CoV-2 infection [78] . TRF was reported to increase markers of autophagy in overweight humans [62] and decreased oxidative stress [61, 63] .

Much of what we know about the effects of IF on the gut comes from animal studies. Compared to AL-fed controls, a fasting mimicking diet (FMD) has been shown to increase the diversity of the gut microbiota and decrease the Firmicutes: Bacteroidetes ratio; the resulting phenotype is consistent with that of a healthy, lean gut [80] . At the genus level, the FMD group showed decreases in several genera that were positively correlated with fasting blood glucose as well as increases in genera that were negatively correlated with fasting glucose [80] . In a separate study in HFD-induced obese mice, compared to AL-fed controls, ADF-fed mice showed significant changes in gut microbiota composition and significant metabolic improvements that were abolished in microbiota-depleted mice [81] . Finally, IF has been shown to reduce widespread systemic inflammation in a gut-dependent manner [73] . Taken together, these studies suggest that IF-mediated benefits to gut health could improve metabolic and immune health, thus ameliorating outcomes for COVID-19 patients.

As we have reviewed, obesity and T2DM increase the incidence of severe complications, cytokine storms, and mortality from COVID-19. Disparities in vaccine distribution, vaccine hesitancy, and the emergence of SARS-CoV-2 variants are barriers to achieving population immunity, increasing the potential for continued outbreaks, hospitalizations, and mortality resulting from COVID-19 illness [9] . With both obesity and COVID-19 on the rise, it is more important than ever to develop strategies that could reduce inflammation, improve glycemic control, and boost immune health. Naturally, this necessitates curbing overnutrition and maladaptive eating habits that lead to poor metabolic health. We have highlighted the numerous beneficial effects of IF on adiposity, metabolic health, glucose homeostasis, the anti-viral J o u r n a l P r e -p r o o f immune response, long-term immunity, inflammatory markers and the gut. One critical question remains surrounding the long-term efficacy of COVID-19 vaccination in obese individuals (see Outstanding Questions), as memory T cell activation and responses to vaccination are blunted in this population [10, 11, 44] . In a recent study, an obesity-related microenvironment in mice promoted the emergence of more virulent pathogenic influenza virus strains that induced greater disease severity in lean hosts [38] . This raises the intriguing possibility that obese metabolic phenotypes could impact future generations of novel COVID-19 variants.

As a result of the COVID-19 pandemic, billions of individuals continue to practice various measures of social distancing and imposed lockdowns. This has resulted in increased sedentary lifestyles and prolonged periods of social isolation, which have been reported to be detrimental to physical and mental health [82, 83] . Globally, eating habits have drastically changed during the pandemic [84] [85] [86] . Generally, more time spent cooking and eating at home, less time spent exercising, boredom, and stress have all given rise to overeating and mindless snacking [85] [86] [87] .

Pandemic-induced lifestyle changes have also led some to increase their focus on healthy eating and seek out strategies to boost their immunity and health [84, 87] . Given the current social climate, with limited opportunities for physical activity, dietary changes such as IF regimens may be a practical way to curb unhealthy eating habits and maximize metabolic health during the pandemic. In particular, TRF regimens have been associated with decreased feelings of hunger throughout the day, curbing non-hungry snacking and mindless eating [57, 63] . Furthermore, IF is also associated with improvements in mood and emotional well-being [88, 89] (Figure 4 , Key Figure) . We propose that TRF or IF may be more sustainable than traditional diets because it J o u r n a l P r e -p r o o f allows individuals to maintain their usual diets with shorter eating durations. In many studies, reducing the duration of eating each day, led to unintentional decreases in caloric intake leading to weight loss and associated metabolic benefits [57, 59] . However, IF has been shown to have positive metabolic consequences, such as improved glucose homeostasis, even in the absence of weight reduction and/or no changes in overall energy expenditure [63] [64] [65] . It must be cautioned that most of the evidence for these findings are from small controlled clinical trials, and an absence of significant effects of TRF on weight and metabolic parameters has also been reported [90] . Importantly, IF regimens have not been addressed in relation to COVID-19 illness (see Outstanding Questions). Ultimately, as outlined in Box 2, a combination of nutritional lifestyles and physical activity are likely most effective.

Finally, there are some concerns as to whether IF strategies are appropriate for everyone. It is possible that certain dietary regimes involving reduced caloric intake could harness immunosuppressive effects, thus weakening the anti-SARS-CoV-2 immune response [91] . There are also limited reports on the effects of IF in elderly populations. Although IF has been shown to have physical and mental benefits in an elderly population (>65 years of age) [92] , caution must be exercised when recommending fasting strategies to improve health for the elderly and those with weakened immunity (see Outstanding Questions).

In conclusion, while IF is an exciting and growing field of investigation, further research efforts are needed to establish the effects of IF on anti-viral immunity, particularly in the context of COVID-19. Given that IF has shown profound promise in improving metabolic health, we argue that now is a better time than ever to adopt this healthy lifestyle strategy (Figure 4 ).

Infection with SARS-CoV-2 elicits a wide spectrum of clinical responses, ranging from asymptomatic infection to severe multisystem failure and respiratory distress. During the initial phase of infection, the entry of SARS-CoV-2 into the host cells activates innate immune signaling cascades, leading to increased secretion of pro-inflammatory cytokines, followed by functional adaptive immune responses that are critical for recovery and long-term immunity [93] .

Approximately one week after the onset of coronavirus disease (COVID-19) symptoms, SARS-CoV-2-specific B and T cell responses can be detected in the blood [94] . These initial immune responses play a vital role in viral clearance through antibody production, the direct killing of virus-infected cells, and the production of cytokines that aid in immune cell recruitment [93, 94] .

While the majority of COVID-19 cases exhibit mild to moderate symptoms and eventually recover, approximately 15% exhibit dysfunctional immune responses characterized by uncontrolled pro-inflammatory cytokine release [95, 96] . This state of hyper-inflammation, termed a cytokine storm, is thought to be the main driver of tissue injury, resulting in acute respiratory distress syndrome (ARDS), multi-organ failure, and ultimately death [32] . Thus, compared to individuals who experience normal recovery, patients with severe COVID-19 infection exhibit markedly increased serum levels of numerous pro-inflammatory cytokines (e.g., IL-6, IL-1, IL-2, IL-8, IL-17, G-CSF, GM-CSF, leptin and TNF-) accompanied by immune cell impairment (e.g., higher percentages of pathogenic inflammatory monocytes, which propagate cytokine storms) [8, 32, 97] . Decreased lymphocyte counts and abnormal lymphocyte functionality, including T cell exhaustion, have also been associated with increased COVID-19 severity [32, 93] .

Restriction of energy intake has beneficial effects on human health, including extended longevity, disease protection, and delayed aging [74, 98] . To address the difficulty of adhering to conventional, calorically restrictive weight loss regimes, intermittent fasting (IF) has gained popularity as an effective and practical alternative. Recently, IF has been shown to be an effective intervention for body weight regulation and glycemic control in many preclinical and clinical studies [59-61, 64, 65] . Unlike caloric restriction (CR), which is defined as a chronic 20-40% reduction of total caloric intake without any changes in meal frequency or timing [74] , IF involves recurring periods of fasting, alternating with ad libitum (AL) food consumption [56] .

Subtypes of IF are described in Figure I . Regular exercise of moderate to high intensity has been shown to reduce body weight and fat mass, however, evidence suggests that exercise alone generally leads to modest or clinically insignificant weight loss [99] . One trial assessed the effects of combining IF with endurance exercise 3-days per week for 12 weeks in obese adults [100] . While body weight and BMI were reduced in both groups, the combination of both interventions resulted in a superior reduction in these parameters [100] . Interestingly, fat mass significantly decreased in the IF and combination group, but not the exercise group, potentially highlighting limitations of exercise alone as an anti-obesity approach [100] . In contrast, one meta-analysis found that combining IF with resistance training exercise had either small or inconsistent effects on decreasing body and fat mass when compared to resistance training alone [101] , indicating a need for further studies to validate the advantages of combining exercise with IF.

As recent evidence suggests that physical activity is protective against severe COVID-19 outcomes [102] , a lifestyle that incorporates both physical activity and dietary intervention is likely an ideal approach to mitigating the impacts of COVID-19. However, during the COVID-19 pandemic, evidence suggests that social distancing has increased barriers to participation in physical activity [83] . One benefit of IF is that it is a zero-cost and time approach to managing weight, whereas exercise generally requires time, resources and access to facilities, barriers associated with inactivity [103] . Thus, while exercise and IF are both attractive options for managing weight, IF may be a more pragmatic approach for some, particularly during the global pandemic. See Figure I for a description and comparison of weight loss approaches.

SARS-CoV-2 gains entry into host cells through binding of its envelope spike protein to the human cell receptor angiotensin-converting enzyme 2 (ACE2) [104] . The serine protease transmembrane serine protease 2 (TMPRSS2), is essential for ACE2-receptor mediated binding viral entry [104] . ACE2 is expressed ubiquitously with highest expression in the digestive system, specifically ileal epithelial cells, as well as in the lungs, kidneys, heart, bladder, and adipose tissue [48] . In the lungs, alveolar type II pneumocytes (AT2 cells) and transient bronchial secretory cell populations co-express ACE2 and TMPRSS2, and are suspected to be the main targets for SARS-CoV-2 infection [105] .

ACE2 is an important negative regulator to the renin-angiotensin-system (RAS) [106] . Signaling of angiotensin II (AngII) through the angiotensin II type 1 receptor promotes vasoconstrictive responses [106] . ACE2 catalyzes cleavage of AngII, producing angiotensin 1-7, a vasodilator associated with beneficial regulation of blood pressure homeostasis [106] .

Adipose tissue, where ACE2 is highly expressed and is even further upregulated in obesity, has been reported to be a reservoir for SARS-CoV-2 [107] . The relationship between adipocyte expression of ACE2 and pathogenesis of COVID-19, however, is unknown. ACE2 expression was significantly upregulated in lung tissue from obese mice compared to lean mice and both ACE2 and TMPRSS2 were increased in human lung epithelial cells from obese subjects compared to non-obese individuals [108] , which could enhance entry of SARS-CoV-2 into the cell. However, SARS-CoV-2 infection downregulates expression of ACE2, a process theorized to contribute to lung injury and increase disease severity [104, 109] . Based on observations that conditions reported to be strongly associated with severe symptoms of COVID-19 infection show a degree of ACE2 deficiency, it has been suggested that the downregulation of ACE2 induced by entry of SARS-CoV-2 into the host cell may be particularly detrimental in individuals with a baseline deficiency of ACE2, who may have more marked imbalance of the RAS system [104] . Therapies that can increase baseline ACE2 expression may reduce exaggerated imbalance of the Ras system upon COVID-19 infection. Notably, in mice a 4-week IF treatment mitigated HFD-induced increases in systolic blood pressure and increased left ventricular expression of ACE2 associated with beneficial remodeling of cardiac tissue [110] .

Furthermore, human studies have also reported positive benefits of IF on hypertension [58, 63] .

Evidently, the relationship between tissue ACE2 expression and susceptibility to SARS CoV-2 infection as well as COVID-19 pathogenesis is complex and warrants further investigation. Hyperglycemia and poor glycemic control are independently associated with the severity of COVID-19 and increase the risk of mortality [17-19, 21, 22] . The pathophysiological mechanisms for this association may be related to increased activation of glucose metabolic pathways. Increased hexosamine biosynthesis by viral-infection contributes to cytokine storms through upregulation of interferon regulatory factor-5 (IRF-5) [23, 24] , a marker of metabolic inflammation that is elevated in adipose tissues of obese individuals [25, 26] . Hyperglycemia was associated with increased SARS-CoV-2 replication in monocytes from human obese diabetic patients, leading to sustained viral proliferation, induction of cytokine storm, and T cell J o u r n a l P r e -p r o o f dysfunction [8] . Furthermore, hyperglycemia may potentiate glycosylation of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) [28, 29] .

J o u r n a l P r e -p r o o f The accumulation of excess fat is characterized by a phenotypic shift from an anti-inflammatory to a pro-inflammatory tissue microenvironment, including an increased ratio of proinflammatory (M1-like) to anti-inflammatory (M2-like) macrophages, enhanced polarization towards Th1, Th17 and CD8+ cytotoxic T cells, and reduced regulatory T cells [7] . These changes result in an increase in baseline circulating levels of pro-inflammatory cytokines (e.g., IL-6, TNF-, IL-1 and leptin) [7, 33] and frequency of monocytes. Increased pro-inflammatory cytokines may exacerbate the risk of viral-induced cytokine storms and drive tissue injury, resulting in acute respiratory distress syndrome (ARDS), multi-organ failure, and ultimate death [12, 97] . Attenuated immune cell activation and impaired memory T cell responses in obese populations result in poor outcomes from viral infection and reduce efficacy of vaccines [10] . While the number of vaccine candidates for COVID-19 continues to increase, many hurdles exist surrounding global distribution, access and vaccine hesitancy [9] . Thus, the feasibility of tackling this global pandemic and achieving population herd immunity remains unclear. In addition to these challenges, second and third waves of infection have resulted in stay-at -home orders and imposed lockdowns for billions of individuals worldwide. The toll of widespread social isolation includes a shift to more sedentary lifestyles, drastic changes in eating and lifestyle habits, and increased stress culminating in declining physical and mental health [82, 84, 86, 87] . We propose that incorporation of healthy eating strategies, such as IF, that are reported to boost immune health, restore metabolic function, and improve glucose homeostasis are especially important Lifestyle interventions that support the management of obesity and promote metabolic health include, caloric restriction (CR), alternate-day fasting (ADF), time-restricted feeding (TRF) and physical exercise. These interventions have all been shown to improve body composition and glucose homeostasis [56, 63, 98, 99] . Unlike ADF and TRF (subtypes of IF), exercise regimes require time and, often, financial resources to implement. Depending, this can be a burden associated with CR regimes as well. Moreover, energy intake is chronically restricted with CR, creating unique challenges for long-term adherence. A major benefit of ADF and TRF is that overall energy intake is not restricted, although this is often an unintended consequence of these regimes [59] . Meal timing is, however, restricted with IF, posing distinct adherence challenges.

The figures were created with BioRender.com. J o u r n a l P r e -p r o o f

Due to the relative speed at which coronavirus disease 2019 (COVID-19) vaccines were developed, tested and approved there is currently no long-term data on their efficacy in obese populations. Will long-term immunity from COVID-19 vaccination be hampered in obese individuals, as has been observed for other vaccines? We predict that obese individuals would experience quicker declines in vaccine-induced immunity compared to lean individuals, making this population at a higher risk of infection and resulting in negative consequences for the overall success of COVID-19 vaccination programs worldwide.

Most clinical trials of intermittent fasting (IF) have examined small samples of participants over relatively short periods of time. Evidence as to whether adherence can be sustained in the longterm is forthcoming. Furthermore, much of the evidence for the impact of IF and/or caloric restriction on adaptive immunity, memory T cells, immune system reset, and gut health, which are critical parameters of anti-viral immunity, have come from preclinical studies. This raises the question of whether IF strategies can impact immunopathological mechanisms specific to SARS-CoV-2. There is a critical need for studies testing the role of dietary strategies, including IF, in improving anti-viral immunity and reducing the severity of COVID-19.

In this paper, we provide evidence that IF may help reduce the risk of severe COVID-19 in obese, diabetic, and/or metabolically unhealthy individuals. However, it is less clear whether these putative benefits extend to lean, metabolically healthy individuals. Given that the risk of developing severe COVID-19 symptoms is greatly increased in older individuals as well as in those with weakened immune systems and pre-existing conditions, it is conceivable that IF could J o u r n a l P r e -p r o o f

Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study

Obesity is a potential risk factor contributing to clinical manifestations of COVID-19

High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation

Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry

Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx

Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis

2021) Five reasons why COVID herd immunity is probably impossible

Increased risk of influenza among vaccinated adults who are obese

Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus

An inflammatory cytokine signature predicts COVID-19 severity and survival

IL-6-based mortality risk model for hospitalized patients with COVID-19

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Diabetes is a risk factor for the progression and prognosis of COVID-19

Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

Glycemic Characteristics and Clinical Outcomes of COVID-19

Patients Hospitalized in the United States

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19

Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry

Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes

Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study

O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5

Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia

Enhanced Adipose Expression of Interferon Regulatory Factor (IRF

Associates with the Signatures of Metabolic Inflammation in Diabetic Obese Patients

Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity

Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

2021) Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike

2020) Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic

Obesity results in adipose tissue T cell exhaustion

Clinical and immunological features of severe and moderate coronavirus disease 2019

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo

Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation

Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity

Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue

Leptin correlates with monocytes activation and severe condition in COVID-19 patients

Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains

Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells

Obesity-Induced Changes in T-Cell Metabolism Are Associated With Impaired Memory T-Cell Response to Influenza and Are Not Reversed With Weight Loss

Obesity decreases B cell responses in young and elderly individuals

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Obesity may hamper SARS-CoV-2-specific vaccine

Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions

Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Homeostatic Immunity and the Microbiota

The microbiome and critical illness

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front Immunol

Intermittent Fasting: Physiological Implications on Outcomes in Mice and Men

A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits

Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome

Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study

Adherence to Time-Restricted Feeding and Impact on Abdominal Obesity in Primary Care Patients: Results of a Pilot Study in a Pre-Post Design

Effects of 4-and 6-h Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults with Obesity

Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans

Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes

Thermogenesis-independent metabolic benefits conferred by isocaloric intermittent fasting in ob/ob mice

Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage

Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in

Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes. Front Endocrinol (Lausanne)

The influence of different calorie restriction protocols on serum proinflammatory cytokines, adipokines and IGF-I levels in female C57BL6 mice: short term and long term diet effects

Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects

The effects of diurnal intermittent fasting on proinflammatory cytokine levels while controlling for sleep/wake pattern, meal composition and energy expenditure

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota

Fasting: molecular mechanisms and clinical applications

Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool

The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction

Prolonged fasting reduces IGF-1/PKA to promote hematopoieticstem-cell-based regeneration and reverse immunosuppression

Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response

Autophagy Dysregulation and Obesity-Associated Pathologies

Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores beta cells and reconstructs gut microbiota in mice

Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota

Psychological Consequences of Social Isolation During COVID-19 Outbreak

Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review

Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey

Lockdown in the Danish Population: The Danish COVIDiet Study. Front Nutr

Global Changes and Factors of Increase in Caloric/Salty Food Intake, Screen Use, and Substance Use During the Early COVID-19 Containment Phase in the General Population in France: Survey Study

COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus

Efficacy of fasting and calorie restriction (FCR) on mood and depression among ageing men

A review of effects of calorie restriction and fasting with potential relevance to depression

Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial

Age, calorie restriction, and age of calorie restriction onset reduce maturation of natural killer cells in C57Bl/6 mice

The Effects of Time Restricted Feeding on Overweight, Older Adults: A Pilot Study

Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front Immunol

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Cases From the Chinese Center for Disease Control and Prevention

Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes

Health Benefits of Fasting and Caloric Restriction

Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: An overview of 12 systematic reviews and 149 studies

Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans

Effects of intermittent fasting combined with resistance training on body composition: a systematic review and meta-analysis

Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients

Predictors of perceived barriers to physical activity in the general adult population: a cross-sectional study

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

The Role of Adipocytes and Adipocyte-Like Cells in the Severity of COVID-19 Infections

Regulation of Angiotensin-Converting Enzyme 2 in Obesity: Implications for COVID-19

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

gut physiology, including increased barrier permeability and microbiome dysbiosis [51]. As the gastrointestinal system (GI) is thought to be a target for SARS-CoV-2 entry, poor gut health to the unique social climate of stay-at-home orders as they do not require major alterations in diet composition, but instead, restrict eating to discrete time windows. . Ultimately, further investigation is needed to clarify whether the putative benefits and safety profile of IF are dependent on the